The Clinical Trials Market is expected to be around US$ 66.15 Billion by 2028 at a CAGR of 5.04% in the given forecast period.
Research studies performed over people, with the purpose of evaluating a surgical, medical, or behavioural intervention are called Clinical trials. Clinical trials are also used with the resolution of trying to invent ways to detect a disease in its early stages, sometimes before the indications of the disease begin to affect the body. Other times, clinical trials are performed to test ways to prevent a health problem. Clinical trials may also test the efficiency of methods that aim at improving the physical condition of people suffering from a life-threatening disease or a chronic health problem. The major setback faced by clinical trials is that they usually deal with vulnerable populations that are at the maximum risk of exposure to coronavirus such as patients or geriatric population with pre-existing conditions. Moreover, numerous clinical trials are noted to have been postponed or suspended amidst operational complications inflicted due to restriction on the movement of individuals. The growing requirement to develop new therapeutics for chronic diseases such as cardiovascular disease, cancer, respiratory disorder, diabetes, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 and the growing demand for developing a suitable treatment for the same is driving the market’s development.
The global Clinical Trials market is segregated on the basis of Phases as Phase I, Phase II, Phase III, and Phase IV. Based on Study Design the global Clinical Trials market is segmented in Interventional Study, Observational Study, and Expanded Access Study. Based on Therapeutic Area the global Clinical Trials market is segmented in Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology, and Others.
The global Clinical Trials market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Clinical Trials market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
ICON Plc, Wuxi AppTec, PRA Health Sciences, SGS SA, Syneos Health, Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Clinipace, and others are among the major players in the global Clinical Trials market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Clinical Trials Market has been segmented as below:
Clinical Trials Market, By Phases
Clinical Trials Market, By Study Design
Clinical Trials Market, By Therapeutic Area
Clinical Trials Market, By Region
Clinical Trials Market, By Company
The report covers:
Report Scope:
The global Clinical Trials market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Clinical Trials market share. Major industry players with significant revenue share include ICON Plc, Wuxi AppTec, PRA Health Sciences, SGS SA, Syneos Health, Eli Lilly and Company, Novo Nordisk A/S, Pfizer, Clinipace, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Ventricular Assist Device Market
Continuous Renal Replacement Therapy (CRRT) Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Clinical Trials Market, By Phases
5.1. Key Points
5.2. Phase I
5.3. Phase II
5.4. Phase III
5.5. Phase IV
6. Clinical Trials Market, By Study Design
6.1. Key Points
6.2. Interventional Study
6.3. Observational Study
6.4. Expanded Access Study
7. Clinical Trials Market, By Therapeutic Area
7.1. Key Points
7.2. Autoimmune Disease
7.3. Oncology
7.4. Cardiology
7.5. Infectious Disease
7.6. Dermatology
7.7. Ophthalmology
7.8. Others
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profiles
9.1 ICON Plc
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Wuxi AppTec
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 PRA Health Sciences
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 SGS SA
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Syneos Health
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Eli Lilly and Company
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Novo Nordisk A/S
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Pfizer
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Clinipace
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
The Clinical Trials Market has been segmented as below:
Clinical Trials Market, By Phases
Clinical Trials Market, By Study Design
Clinical Trials Market, By Therapeutic Area
Clinical Trials Market, By Region
Clinical Trials Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
